These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16837170)

  • 1. Recombinant human activated protein C.
    Hughes M
    Int J Antimicrob Agents; 2006 Aug; 28(2):90-4. PubMed ID: 16837170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Xigris--activated protein C].
    Tønnesen EK
    Ugeskr Laeger; 2004 Mar; 166(11):1002-4. PubMed ID: 15049235
    [No Abstract]   [Full Text] [Related]  

  • 3. Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
    McLeay AM
    Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human activated protein C for severe sepsis.
    Ott A; Verbrugh HA
    N Engl J Med; 2001 Jul; 345(3):220; author reply 220-1. PubMed ID: 11463023
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human activated protein C for severe sepsis.
    Kapur S; Kupfer Y; Tessler S
    N Engl J Med; 2001 Jul; 345(3):219-20; author reply 220-1. PubMed ID: 11463021
    [No Abstract]   [Full Text] [Related]  

  • 6. Sepsis and the role of activated protein C.
    Tazbir J
    Crit Care Nurse; 2004 Dec; 24(6):40-5. PubMed ID: 15646088
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human activated protein C for severe sepsis.
    Greisman SE; Johnston CA; Gosnell MS
    N Engl J Med; 2001 Jul; 345(3):219; author reply 220-1. PubMed ID: 11463022
    [No Abstract]   [Full Text] [Related]  

  • 8. Drotrecogin alfa (activated) for severe sepsis.
    Maglio D
    Conn Med; 2002 Mar; 66(3):145-50. PubMed ID: 11957766
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe sepsis with Xigris: implications for the clinical nurse specialist.
    Powers J; Jacobi J
    Clin Nurse Spec; 2003 May; 17(3):128-30. PubMed ID: 12792186
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis.
    Grinnell BW; Joyce D
    Crit Care Med; 2001 Jul; 29(7 Suppl):S53-60; discussion S60-1. PubMed ID: 11445735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human-activated protein C (rhAPC) in childhood sepsis.
    Frassica JJ; Vinagre YM; Maas B
    J Intensive Care Med; 2004; 19(1):56-7. PubMed ID: 15035756
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activated protein C--recent addition to therapy of sepsis].
    Gårdlund B; Sjölin J
    Lakartidningen; 2003 Jun; 100(26-27):2292-6. PubMed ID: 12872375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drotrecogin alpha (activated).
    Labbos J; Bradsher J; Kirkpatrick P
    Nat Rev Drug Discov; 2003 Jan; 2(1):13-4. PubMed ID: 12521028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activated protein C and treatment of sepsis].
    Høibraaten E; Vangerow B
    Tidsskr Nor Laegeforen; 2004 May; 124(10):1422; author reply 1422-3. PubMed ID: 15195189
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human activated protein C for severe sepsis.
    O'Connor PE
    N Engl J Med; 2001 Jul; 345(3):220; author reply 220-1. PubMed ID: 11463024
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis.
    Dhainaut JF
    Am J Surg; 2002 Dec; 184(6A Suppl):S5-10. PubMed ID: 12521612
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new drug which saves lives. Sepsis: chaos in the body--recent aspects of pathophysiology and therapy].
    Haas I
    Krankenpfl J; 2002; 40(10-12):310-4. PubMed ID: 12600015
    [No Abstract]   [Full Text] [Related]  

  • 18. [PROWESS--milestone in lowering sepsis mortality].
    Reinhart K
    Krankenpfl J; 2002; 40(10-12):315. PubMed ID: 12600016
    [No Abstract]   [Full Text] [Related]  

  • 19. Drotrecogin Alfa (Activated): From Bench to Practical Use at the Bedside. Proceedings of meetings of the Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Clinical Evaluation Committee.
    Am J Surg; 2002 Dec; 184(6A Suppl):1S-49S. PubMed ID: 12521610
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of severe sepsis and multiple organ failure with activated protein C].
    Strøm JJ
    Ugeskr Laeger; 2004 Mar; 166(11):995. PubMed ID: 15049233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.